Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
QWEST CORPORATION 6.125 NOTES DUE 2053
(NQ:
CTY
)
19.20
+0.53 (+2.84%)
Delayed Quote
Updated: 2:13 PM EST, Nov 10, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about QWEST CORPORATION 6.125 NOTES DUE 2053
City Therapeutics Announces First Participant Dosed in Phase 1 Clinical Trial of CITY-RBP4 for the Treatment of Stargardt Disease
Today 7:00 EST
From
City Therapeutics
Via
GlobeNewswire
Phase 1 Data for CITY-FXI, an RNAi Therapeutic Candidate for Thromboembolic Diseases, Selected for Oral Presentation at the 68th ASH Annual Meeting
November 04, 2026
Preclinical data supporting CITY-TFR2 for anemia of chronic disease to be presented in a poster session
From
City Therapeutics
Via
GlobeNewswire
City Therapeutics to Present at Upcoming November Investor Conferences
November 03, 2026
From
City Therapeutics
Via
GlobeNewswire
City Therapeutics Announces Closing of $230.0 Million Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
October 19, 2026
From
City Therapeutics
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.